Skip to main content

SB 2257

AN ACT relating to the definition and provision of an abortion-inducing

Senate Bill Cook
Filed

Filed

Bill introduced by legislator

Committee

Hearing

Passed Cmte

Calendar

Passed

Sent

Enrolled

Governor

Signed

89th Regular Session

Jan 14, 2025 - Jun 2, 2025 • Session ended

Awaiting Committee Assignment

Bill filed, pending referral to Senate committee

← Back to Bills

Committee

Not yet assigned

Fiscal Note

Not available

What This Bill Does

relating to the definition and provision of an abortion-inducing

Subject Areas

Bill Text

relating to the definition and provision of an abortion-inducing
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1.  Section 171.061(2), Health and Safety Code, is
(2)  "Abortion-inducing drug" means a drug, a medicine,
or any other substance, including a regimen of two or more drugs,
medicines, or substances, prescribed, dispensed, or administered
with the intent of terminating a clinically diagnosable pregnancy
of a woman and with knowledge that the termination will, with
reasonable likelihood, cause the death of the woman's unborn
child.  The term includes off-label use of drugs, medicines, or
other substances known to have abortion-inducing properties that
are prescribed, dispensed, or administered with the intent of
causing an abortion, including the Mifeprex regimen, and
misoprostol (Cytotec)[, and methotrexate].  The term does not
include a drug, medicine, or other substance that may be known to
cause an abortion but is prescribed, dispensed, or administered for
SECTION 2.  Section 171.063(c), Health and Safety Code, is
(c)  Before the physician provides an abortion-inducing
(1)  examine the pregnant woman in person;
(2)  independently verify that a pregnancy exists;
(3)  [document, in the woman's medical record, the
gestational age and intrauterine location of the pregnancy to
determine whether an ectopic pregnancy exists;
[(4)]  determine the pregnant woman's blood type, and
for a woman who is Rh negative, offer to administer Rh
immunoglobulin (RhoGAM) at the time the abortion-inducing drug is
administered or used or the abortion is performed or induced to
prevent Rh incompatibility, complications, or miscarriage in
(4) [(5)]  document whether the pregnant woman
received treatment for Rh negativity, as diagnosed by the most
accurate standard of medical care; and
(5) [(6)]  ensure the physician does not provide an
abortion-inducing drug for a pregnant woman whose pregnancy is more
than 49 days of gestational age.
SECTION 3.  (a) The changes in law made by this Act apply
only to an offense committed on or after the effective date of this
Act.  An offense committed before the effective date of this Act is
governed by the law in effect on the date the offense was committed,
and the former law is continued in effect for that purpose.  For
purposes of this section, an offense was committed before the
effective date of this Act if any element of the offense occurred
(b)  The changes in law made by this Act apply only to the
imposition of an administrative penalty for a violation that occurs
on or after the effective date of this Act. The imposition of an
administrative penalty for a violation that occurs before the
effective date of this Act is governed by the law in effect on the
date the violation occurred, and the former law is continued in
SECTION 4.  This Act takes effect September 1, 2025.

Bill History

filed

Bill filed: AN ACT relating to the definition and provision of an abortion-inducing